US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
カナダ
CSE
Algernon Pharmaceuticals Inc (AGN)
Algernon Pharmaceuticals Inc (AGN) ニュース

AGN

Algernon Pharmaceuticals (AGN)

Algernon Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:CSE:AGN

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/02/11	22 : 00	InvestorsHub NewsWire	Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol	CSE:AGN	Algernon Pharmaceuticals Inc
2020/06/05	01 : 41	InvestorsHub NewsWire	Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19	CSE:AGN	Algernon Pharmaceuticals Inc
2020/04/13	22 : 44	InvestorsHub NewsWire	Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard	CSE:AGN	Algernon Pharmaceuticals Inc
2020/03/13	21 : 40	InvestorsHub NewsWire	Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency	CSE:AGN	Algernon Pharmaceuticals Inc
2020/03/06	22 : 32	InvestorsHub NewsWire	Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus	CSE:AGN	Algernon Pharmaceuticals Inc
2019/07/31	20 : 22	InvestorsHub NewsWire	Algernon Pharmaceuticals Announces Russian Athletic Performance Enhancing Drugs Bemethyl (NP-135) and Bromantane (NP-160) ...	CSE:AGN	Algernon Pharmaceuticals Inc
2019/07/29	21 : 32	InvestorsHub NewsWire	Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis ...	CSE:AGN	Algernon Pharmaceuticals Inc
2019/07/03	22 : 06	InvestorsHub NewsWire	Algernon Pharmaceuticals' NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56%	CSE:AGN	Algernon Pharmaceuticals Inc
2019/06/04	21 : 00	InvestorsHub NewsWire	Q&A with Christopher J. Moreau CEO of Algernon Pharmaceuticals	CSE:AGN	Algernon Pharmaceuticals Inc
2019/05/28	21 : 00	InvestorsHub NewsWire	Algernon Pharmaceuticals: Join us for an interview with the CEO and CSO	CSE:AGN	Algernon Pharmaceuticals Inc
2019/05/23	21 : 04	InvestorsHub NewsWire	Repurposing Drugs Reduces Investment Risk. Algernon Pharma Plans Phase 2 Trials for NASH, CKD and IBD	CSE:AGN	Algernon Pharmaceuticals Inc

Showing the most relevant articles for your search:CSE:AGN

1

US Dollar vs Sterling

Verizon Communications

US Dollar vs Euro

Bank of America

Health Care Select Sector

American Express

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約